133 related articles for article (PubMed ID: 9285079)
21. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test.
Verbaten MN; Overtoom CC; Koelega HS; Swaab-Barneveld H; van der Gaag RJ; Buitelaar J; van Engeland H
J Abnorm Child Psychol; 1994 Oct; 22(5):561-78. PubMed ID: 7822629
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study.
Faraone SV; Short EJ; Biederman J; Findling RL; Roe C; Manos MJ
Int J Neuropsychopharmacol; 2002 Jun; 5(2):121-9. PubMed ID: 12135536
[TBL] [Abstract][Full Text] [Related]
23. Effects of methylphenidate on event-related potentials and performance of attention-deficit hyperactivity disorder children in auditory and visual selective attention tasks.
Jonkman LM; Kemner C; Verbaten MN; Koelega HS; Camfferman G; vd Gaag RJ; Buitelaar JK; van Engeland H
Biol Psychiatry; 1997 Mar; 41(6):690-702. PubMed ID: 9066993
[TBL] [Abstract][Full Text] [Related]
24. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
25. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
26. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate.
Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Kenemans JL; Camfferman G; Buitelaar JK; Koelega HS
Psychophysiology; 1999 Jul; 36(4):419-29. PubMed ID: 10432791
[TBL] [Abstract][Full Text] [Related]
27. Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.
Lawrence CA; Barry RJ; Clarke AR; Johnstone SJ; McCarthy R; Selikowitz M; Broyd SJ
Psychopharmacology (Berl); 2005 Nov; 183(1):81-91. PubMed ID: 16160877
[TBL] [Abstract][Full Text] [Related]
28. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
29. Event-related potentials reflect the efficacy of pharmaceutical treatments in children and adolescents with attention deficit/hyperactivity disorder.
Yamamuro K; Ota T; Iida J; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto N; Tanaka S; Kishimoto T
Psychiatry Res; 2016 Aug; 242():288-294. PubMed ID: 27318633
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
31. Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD.
Teicher MH; Lowen SB; Polcari A; Foley M; McGreenery CE
J Child Adolesc Psychopharmacol; 2004; 14(2):219-32. PubMed ID: 15319019
[TBL] [Abstract][Full Text] [Related]
32. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
33. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
[TBL] [Abstract][Full Text] [Related]
34. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
Silk TJ; Newman DP; Eramudugolla R; Vance A; Bellgrove MA
Neuropsychologia; 2014 Apr; 56():178-83. PubMed ID: 24486422
[TBL] [Abstract][Full Text] [Related]
35. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
Wienbruch C; Paul I; Bauer S; Kivelitz H
BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
[TBL] [Abstract][Full Text] [Related]
37. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
[TBL] [Abstract][Full Text] [Related]
38. Methylphenidate in the treatment of an adolescent female with obsessive-compulsive disorder and attention deficit hyperactivity disorder: a case report.
King J; Dowling N; Leow F
Australas Psychiatry; 2017 Apr; 25(2):178-180. PubMed ID: 27683657
[TBL] [Abstract][Full Text] [Related]
39. [Studies of evoked potentials in children with the syndrome of attention deficit and hyperactivity].
Smeyers P
Rev Neurol; 1999 Feb; 28 Suppl 2():S173-6. PubMed ID: 10778509
[TBL] [Abstract][Full Text] [Related]
40. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
Kollins SH; Shapiro SK; Newland MC; Abramowitz A
Exp Clin Psychopharmacol; 1998 Nov; 6(4):375-389. PubMed ID: 9861552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
